Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu.

The biopharmaceutical company reaffirms its commitment to local innovation and manufacturing with the extension of the authorisation obtained in 2011. It will allow it to increase its current production capacity tenfold and boost its CDMO services.   The new manufacturing plant has obtained authorisation from the Spanish Agency for Medicines…

Read more

NEW GENERATION SEQUENCING: A SEQUENCING SERVICE STEP BY-STEP

Since its advent in the 1970s, DNA and RNA sequencing has revolutionised the scientific landscape. A multitude of research projects in fields as diverse as virology or anthropology, including oncology, the study of hereditary diseases or zoology, benefit enormously from access to DNA sequencing techniques. However, most centres do not…

Read more

VIVEbiotech achieves significant business growth in 2023 with increases in demand for its lentiviral vector specialization and capabilities

VIVEbiotech announces significant growth in 2023, with sales increasing by 70%.   Recent company sales grow by 70%, reflecting expanded capabilities and industry recognition of VIVEbiotech’s expertise in manufacturing lentiviruses, now used in in 70% of global ex-vivo CGT clinical trials VIVEbiotech is able to manufacture integrating, and non-integrating, different…

Read more